Clinical trial Recruiting at 1 site Interventional Ages 18 to 38 Women only

Improving egg freezing techniques for fertility treatments

Official title: Validation of Semi-automatic Oocyte Vitrification by the GAVI® Machine in Medically Assisted Reproduction With Oocyte Donation

Run by University Hospital, Clermont-Ferrand · NCT06238570 · Data updated 2026-11-12

This study is testing a new way to freeze donor eggs to see if it helps them survive better and leads to more successful pregnancies when used in fertility treatments.

Quick facts

Study typeInterventional
Ages18 Years to 38 Years
SexWomen only
Enrollment50 (estimated)
SponsorUniversity Hospital, Clermont-Ferrand
Academic / other
Locations1 site (Clermont-Ferrand)
StatusRecruiting
StartedJanuary 23, 2024
Main results expectedSeptember 2026
Study endsDecember 2026
Registry record updatedApril 30, 2026
Trial IDNCT06238570 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women who are egg donors with a good quality ovarian reserve and meet specific health criteria.

Probably not a fit

Patients who are pregnant, lactating, or unable to provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a semi-automated vitrification method for freezing donor oocytes compared to traditional manual techniques. The research aims to assess the survival rates of oocytes after warming and their subsequent fertilization success using intracytoplasmic sperm injection (ICSI). By utilizing closed devices for storage, the study seeks to minimize variability and improve the consistency of oocyte preservation. The outcomes will include the quality of embryos developed from vitrified oocytes and their potential for successful pregnancies in assisted reproductive technology.

Why it matters

Potential benefit: If successful, this study could enhance the success rates of fertility treatments by improving the preservation of donor oocytes.

How similar studies have gone: Previous studies have shown promising results with automated vitrification techniques, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Egg donor
* Oocyte puncture for donation
* Good quality ovarian reserve (Antral follicle count evaluated by ultrasound: CFA ≥ 7)
* Negative serology status (HIV, hepatitis B and C, syphilis, CMV and HTLV)
* Absence of symptoms or COVID contact
* Absence of genetic contraindication to egg donation
* Woman able to give informed consent to participate in research
* Woman affiliated to a social security scheme

Exclusion Criteria:

* Decline to participate
* Pregnant and lactating woman
* Person under guardianship, curatorship, deprivation of liberty, protection of justice

Where it's running

  • CHU de Clermont-Ferrand
    Clermont-Ferrand, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.